MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Total Assets 2011-2026 | IART
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.04 B | 3.78 B | 3.89 B | 3.78 B | 3.62 B | 3.3 B | 3.11 B | 3.21 B | 1.81 B | 1.77 B | 1.58 B | 1.2 B | 1.16 B | 1.14 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.04 B | 1.14 B | 2.67 B |
Quarterly Total Assets Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.67 B | 4.05 B | 4.07 B | 4.07 B | 4.08 B | 3.74 B | 3.78 B | 3.74 B | 3.89 B | 3.81 B | - | 3.67 B | 3.78 B | 3.77 B | 3.71 B | 3.74 B | 3.62 B | 3.62 B | 3.62 B | 3.62 B | 3.3 B | 3.3 B | 3.3 B | 3.3 B | 3.11 B | 3.11 B | 3.11 B | 3.11 B | 3.21 B | 3.21 B | 3.21 B | 3.21 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 1.77 B | 1.77 B | 1.77 B | 1.77 B | 1.59 B | 1.59 B | 1.58 B | 1.58 B | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 1.16 B | 1.16 B | 1.16 B | 1.16 B | 1.14 B | 1.15 B | 1.15 B | 1.15 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.08 B | 1.14 B | 2.64 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.24 | 0.9 % | $ 3.5 M |  USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 10.47 | 0.19 % | $ 1.41 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 12.56 | -3.75 % | $ 1.88 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.61 | -13.93 % | $ 272 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 8.37 | 0.12 % | $ 601 M |  Israel |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 3.95 | -7.49 % | $ 836 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.65 | -4.41 % | $ 35.4 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 71.28 | 0.11 % | $ 106 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 3.92 | -3.21 % | $ 146 M |  France |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.71 | -1.69 % | $ 1.14 B | USA |
 |
Establishment Labs Holdings
ESTA
|
357 M | $ 65.5 | 0.75 % | $ 1.94 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
199 M | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
InMode Ltd.
INMD
|
766 M | $ 13.45 | -1.47 % | $ 869 M | Israel |
 |
Abbott Laboratories
ABT
|
86.7 B | $ 108.49 | -2.04 % | $ 189 B | USA |
 |
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.38 | -3.7 % | $ 336 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 267.99 | -0.55 % | $ 7.56 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.66 | -3.2 % | $ 391 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 30.94 | -5.53 % | $ 1.42 B | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 172.41 | -2.11 % | $ 12.9 B | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 34.03 | 0.86 % | $ 5.07 K | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
66.8 M | $ 3.67 | -1.87 % | $ 151 M | USA |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
470 M | $ 0.41 | 5.24 % | $ 42.1 M | USA |
 |
IRadimed Corporation
IRMD
|
109 M | $ 99.67 | -3.04 % | $ 1.27 B | USA |